Incidental Finding of Granular Cell Tumor in the Ileocecal Valve During Colectomy for Adenocarcinoma [0.03%]
阑尾回肠瓣乳头状颗粒细胞瘤的偶然发现
Anaïs Dziegielewski,Maxime Hamon,Najat Mourra
Anaïs Dziegielewski
A Brief Report of Immunohistochemical Markers to Identify Aggressive Hepatoblastoma [0.03%]
免疫组化标记在鉴别 hepatoblastoma 恶性行为中的作用
Vivekanand Singh,Michelle Manalang,Meenal Singh et al.
Vivekanand Singh et al.
Hepatoblastoma (HB) is the most common malignant liver tumor in children. Although survival of patients has improved significantly over the last 2 decades, a significant number of patients do not respond to standard chemotherapy. We conduct...
Hepatocyte Antigen Expression in Barrett Esophagus and Associated Neoplasia [0.03%]
巴雷特食管及其相关肿瘤的肝细胞抗原表达
Sejal S Shah,Vishal S Chandan
Sejal S Shah
Hepatocyte antigen or hepatocyte paraffin 1 (Hep Par 1) is widely used as a diagnostic immunomarker for hepatocellular carcinoma. It has also been identified as a rate-limiting enzyme of the urea cycle, carbamoyl phosphate synthetase 1. Hep...
Detection of Novel t(12;17)(p12;p13) in Relapsed Refractory Acute Myeloid Leukemia by Anchored Multiplex PCR(AMP)-based Next-Generation Sequencing [0.03%]
采用锚定多重聚合酶链反应（AMP）测序技术检测复发难治急性髓系白血病中的新型t(12;17)(p12;p13)染色体重排
Talha Badar,Laura Johnson,Katelyn Trifilo et al.
Talha Badar et al.
Although several technologies can be used to detect gene fusions, anchored multiplex PCR next-generation sequencing (AMP-NGS) offers the advantage of novel fusion detection and the ability to multiplex multitudinous genes. We applied AMP-NG...
Prognostic Significance of Stromal Versus Intratumoral Infiltrating Lymphocytes in Different Subtypes of Breast Cancer Treated With Cytotoxic Neoadjuvant Chemotherapy [0.03%]
细胞毒性新辅助化疗治疗的不同类型乳腺癌中间质与肿瘤内浸润淋巴细胞的预后意义
Thaer Khoury,Vidya Nagrale,Mateusz Opyrchal et al.
Thaer Khoury et al.
Background: The aim of the study was to investigate if there were differences in associations of stromal versus intratumoral tumor infiltrating lymphocytes (TILs) with pathology complete response (pCR) among breast cancer...
Immunohistochemical Detection of Hematopoietic Cell-specific Protein-Tyrosine Phosphatase (Tyrosine Phosphatase SHP-1) in a Series of Endometrioid and Serous Endometrial Carcinoma [0.03%]
一组子宫内膜样腺癌和浆液性腺癌中血细胞特异性蛋白酪氨酸磷酸酶的免疫组化检测
Giovanna Giordano,Nicoletta Campanini,Matteo Goldoni et al.
Giovanna Giordano et al.
In this study, we evaluated the expression of SHP-1 (PTPN6) in endometrioid (Ec) and serous (Sc) subtypes of endometrial carcinoma by immunohistochemical analysis. In total, 114 patients with Ec carcinoma and 48 patients with Sc carcinoma w...
X-Ray of Excised Cancerous Breast Tissue Does Not Affect Clinical Biomarker Expression [0.03%]
切除的乳腺癌组织的x光片不会影响临床生物标志物的表达
Isaac E Lloyd,Alana L Welm,Yoko DeRose et al.
Isaac E Lloyd et al.
Context: College of American Pathologists (CAP) and the American Society of Clinical Oncology have emphasized the need to reduce preanalytic variables for evaluating predictive biomarker expression in breast cancer. Posto...
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine. Part 3: Technical Validation of Immunohistochemistry (IHC) Assays in Clinical IHC Laboratories [0.03%]
精准医学时代临床免疫组化质量保证的演变（三）：临床免疫组织化学实验室中免疫组织化学(IHC)实验的技术验证
Emina E Torlakovic,Carol C Cheung,Corrado D&#x;Arrigo et al.
Emina E Torlakovic et al.
Validation of immunohistochemistry (IHC) assays is a subject that is of great importance to clinical practice as well as basic research and clinical trials. When applied to clinical practice and focused on patient safety, validation of IHC ...
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine - Part 2: Immunohistochemistry Test Performance Characteristics [0.03%]
精准医学时代的临床免疫组化质量保证的演变（第二部分）：免疫组化检测性能指标
Emina E Torlakovic,Carol C Cheung,Corrado D&#x;Arrigo et al.
Emina E Torlakovic et al.
All laboratory tests have test performance characteristics (TPCs), whether or not they are explicitly known to the laboratorian or the pathologist. TPCs are thus also an integral characteristic of immunohistochemistry (IHC) tests and other ...
Androgen Receptor (AR) Expression in Invasive Male Breast Carcinoma (MBC): An International Multi-Institutional Review of 168 Cases Emphasizing the Potential Use of AR as a Therapeutic Target [0.03%]
雄激素受体（AR）在侵袭性男性乳腺癌（MBC）中的表达：对168例的国际多中心研究，强调了AR作为治疗靶点的潜在作用
Simona Stolnicu,Denisa Moncea,Alis Dema et al.
Simona Stolnicu et al.